Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Targeting non-Smad pathways in TGF-β signaling may improve keloid treatment.

Tofacitinib treatment is used for teenagers with alopecia areata.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

A new mutation in the HJV gene was found in a young woman with juvenile hemochromatosis, causing unusual symptoms like secondary hypothyroidism.

Tofacitinib may help regrow hair in alopecia areata patients.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

Activating TLR3 boosts autophagy gene expression in skin cells.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

SOX4 is crucial for the development of melanoma.

Keratin 17 is crucial for cell growth in wound healing by aiding protein synthesis.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

TRH stimulates human hair growth and extends the hair growth phase.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

A20 protein is crucial for normal skin and hair development.

New hair perming method using tyrosine is gentler and can be done with a blow-dryer.

A new syndrome was linked to two new genetic changes in the MBTPS1 gene in a 14-year-old girl.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.